The following license files are associated with this item:
- QMRO Home
- William Harvey Research Institute
- Centre for Clinical Pharmacology
- Author Correction: Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasis.
Browse
Administrators only